NP / PA
Wiezorek, Emily
Wiezorek, Emily was paid $357K by Medicaid between Jan 2018 and Nov 2024, across 11 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoWIEZOREK, EMILY
CHATHAM, IL 62629
CHATHAM, IL 62629
33aNPI1609310960assigned 12/06/2016
33bProvider typeFamily Nurse Practitioner
28Total paid$357K
24GClaims6,597
24DCodes billed11
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#136 of 3,353
Median peer was paid$25K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 579 | $25K | |
| 2019 | 603 | $35K | |
| 2020 | 279 | $18K | |
| 2021 | 617 | $32K | |
| 2022 | 1,614 | $88K | |
| 2023 | 1,653 | $88K | |
| 2024incomplete | 1,252 | $72K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 2,478 | 2,179 | $164K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 1,910 | 1,767 | $92K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 10% | 895 | 862 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9.7% | 729 | 698 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.0% | 376 | 350 | $25K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 44 | 35 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 108 | 101 | $2K |
| 87634 | <1% | 14 | 14 | $686.40 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 17 | 15 | $197.85 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | 14 | $166.34 |
| 81025 | <1% | 12 | 12 | $57.13 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.